Estimating future hepatitis C morbidity, mortality, and costs in the United States, Am J Public Health, vol.90, pp.1562-1569, 2000. ,
Mechanisms of Synergy Between Alcohol and Hepatitis C Virus, Journal of Clinical Gastroenterology, vol.41, issue.8, pp.761-772, 2007. ,
DOI : 10.1097/MCG.0b013e3180381584
High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities, Drug and Alcohol Dependence, vol.81, issue.3, pp.259-265, 2006. ,
DOI : 10.1016/j.drugalcdep.2005.07.005
Alcoholism is associated with hepatitis C but not hepatitis B in an urban population, Am J Gastroenterol, vol.91, pp.498-505, 1996. ,
Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population, Hepatology, vol.34, issue.4, pp.892-899, 2004. ,
DOI : 10.1002/hep.1840400419
Outcome of hospital care of liver disease associated with hepatitis C in the United States, Hepatology, vol.33, issue.1, pp.201-206, 2001. ,
DOI : 10.1053/jhep.2001.20798
Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems, Journal of Hepatology, vol.44, issue.2, pp.262-266, 2006. ,
DOI : 10.1016/j.jhep.2005.07.027
Natural history of liver fibrosis progression in patients with chronic hepatitis C, The Lancet, vol.349, issue.9055, pp.825-832, 1997. ,
DOI : 10.1016/S0140-6736(96)07642-8
The Effect of Nicotine and Its Interaction with Carbon Tetrachloride in the Rat Liver, Pharmacology & Toxicology, vol.38, issue.3, pp.225-230, 1995. ,
DOI : 10.1111/j.1600-0773.1995.tb01017.x
Alcohol, Smoking, Cofee, and Cirrhosis, American Journal of Epidemiology, vol.136, issue.10, pp.1248-1257, 1992. ,
DOI : 10.1093/oxfordjournals.aje.a116433
Prospective Study of Hepatocellular Carcinoma and Liver Cirrhosis in Asymptomatic Chronic Hepatitis B Virus Carriers, American Journal of Epidemiology, vol.145, issue.11, pp.1039-1047, 1997. ,
DOI : 10.1093/oxfordjournals.aje.a009060
Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview-based study of 1032 patients, Hepatology, vol.50, issue.5, pp.1194-1202, 2005. ,
DOI : 10.1002/hep.20907
Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: A cross validated retrospective assessment, Hepatology, vol.332, issue.6, pp.1564-1571, 2006. ,
DOI : 10.1002/hep.21423
Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S., Cancer, vol.101, issue.5, pp.1009-1017, 2004. ,
DOI : 10.1002/cncr.20427
Cigarette Smoking, Alcohol Drinking, Hepatitis B, and Risk for Hepatocellular Carcinoma in Korea, JNCI Journal of the National Cancer Institute, vol.96, issue.24, pp.1851-1856, 2004. ,
DOI : 10.1093/jnci/djh334
Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma, Journal of Hepatology, vol.42, issue.2, pp.218-224, 2005. ,
DOI : 10.1016/j.jhep.2004.10.005
Smoking and liver cancer in China: case-control comparison of 36,000 liver cancer deaths vs, p.0 ,
The effect of interaction between hepatitis C virus and cigarette smoking on the risk of hepatocellular carcinoma, British Journal of Cancer, vol.51, pp.737-739, 2006. ,
DOI : 10.1002/1097-0142(20010301)91:5<957::AID-CNCR1085>3.0.CO;2-J
Cigarette smoking and hepatic lesions in patients with chronic hepatitis C, Hepatology, vol.34, issue.1, pp.121-125, 2001. ,
DOI : 10.1053/jhep.2001.25385
Relationship of Smoking and Fibrosis in Patients With Chronic Hepatitis C, Clinical Gastroenterology and Hepatology, vol.4, issue.6, pp.797-801, 2006. ,
DOI : 10.1016/j.cgh.2006.03.019
Impact of smoking on histological liver lesions in chronic hepatitis C, Gut, vol.52, issue.1, pp.126-129, 2003. ,
DOI : 10.1136/gut.52.1.126
Smoking and Alanine Aminotransferase Levels in Hepatitis C Virus Infection, Archives of Internal Medicine, vol.162, issue.7, pp.811-815, 2002. ,
DOI : 10.1001/archinte.162.7.811
Nicotine: the link between cigarette smoking and the progression of renal injury?, AJP: Heart and Circulatory Physiology, vol.292, issue.1, pp.76-82, 2007. ,
DOI : 10.1152/ajpheart.00693.2006
Smoking, oxidative stress and inflammation: Impact on resting energy expenditure in diabetic nephropathy, BMC Nephrology, vol.16, issue.9, p.13, 2005. ,
DOI : 10.1093/ndt/16.3.556
Cigarette smoke induces proinflammatory cytokine release by activation of NF-??B and posttranslational modifications of histone deacetylase in macrophages, AJP: Lung Cellular and Molecular Physiology, vol.291, issue.1, pp.46-57, 2006. ,
DOI : 10.1152/ajplung.00241.2005
Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy, J Immunol, vol.156, pp.2384-2390, 1996. ,
Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study, BMJ, vol.332, issue.7549, pp.1064-1069, 2006. ,
DOI : 10.1136/bmj.38779.584028.55
Smoking is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients, European Journal of Clinical Investigation, vol.58, issue.7, pp.459-465, 2006. ,
DOI : 10.1016/S0895-7061(01)02218-X
Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data, Gastroenterology, vol.130, issue.6, pp.1636-1642, 2006. ,
DOI : 10.1053/j.gastro.2006.03.014
Impact of steatosis on progression of fibrosis in patients with mild hepatitis C, Hepatology, vol.34, issue.Suppl 1, pp.82-87, 2005. ,
DOI : 10.1002/hep.20519
Endocannabinoids and Liver Disease. I. Endocannabinoids and their receptors in the liver, AJP: Gastrointestinal and Liver Physiology, vol.294, issue.1, pp.9-12, 2008. ,
DOI : 10.1152/ajpgi.00467.2007
Endocannabinoids as novel mediators of liver diseases, J Endocrinol Invest, vol.29, pp.58-65, 2006. ,
The Endocannabinoid System as an Emerging Target of Pharmacotherapy, Pharmacological Reviews, vol.58, issue.3, pp.389-462, 2006. ,
DOI : 10.1124/pr.58.3.2
Predictors of cessation of marijuana use: an event history analysis, Drug and Alcohol Dependence, vol.50, issue.2, pp.109-121, 1998. ,
DOI : 10.1016/S0376-8716(98)00021-0
One year follow-up of cannabis dependence among long-term users in Sydney, Australia, Drug and Alcohol Dependence, vol.59, issue.3, pp.309-318, 2000. ,
DOI : 10.1016/S0376-8716(99)00131-3
Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases, Expert Opinion on Therapeutic Targets, vol.288, issue.3, pp.403-409, 2007. ,
DOI : 10.1074/jbc.272.35.22330
CB2 receptors as new therapeutic targets for liver diseases, Br J Pharmacol, vol.153, pp.286-295, 2008. ,
The endocannabinoid system as a target for therapeutic drugs, Trends in Pharmacological Sciences, vol.21, issue.6, pp.218-224, 2000. ,
DOI : 10.1016/S0165-6147(00)01482-6
The endocannabinoid system and its therapeutic exploitation, Nature Reviews Drug Discovery, vol.348, issue.9, pp.771-784, 2004. ,
DOI : 10.1006/bbrc.1998.8874
Antifibrogenic role of the cannabinoid receptor CB2 in the liver, Gastroenterology, vol.128, issue.3, pp.742-755, 2005. ,
DOI : 10.1053/j.gastro.2004.12.050
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis, Nat Med, vol.12, pp.671-676, 2006. ,
Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis, Liver International, vol.16, issue.5, pp.477-483, 2004. ,
DOI : 10.1002/hep.510280104
Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis, Nature Medicine, vol.7, issue.7, pp.827-832, 2001. ,
DOI : 10.1038/89953
The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species, The FASEB Journal, vol.21, issue.11, pp.2798-2806, 2007. ,
DOI : 10.1096/fj.06-7717com
cannabinoid receptor antagonism on livers of rats with biliary cirrhosis, Clinical Science, vol.112, issue.10, pp.533-542, 2007. ,
DOI : 10.1042/CS20060260
68 Daily cannabis smoking as a risk factor for fibrosis progression in chronic hepatitis C, Journal of Hepatology, vol.40, pp.63-71, 2005. ,
DOI : 10.1016/S0168-8278(04)90068-2
Influence of Cannabis Use on Severity of Hepatitis C Disease, Clinical Gastroenterology and Hepatology, vol.6, issue.1, pp.69-75, 2008. ,
DOI : 10.1016/j.cgh.2007.10.021
Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis, Gut, vol.53, issue.3, pp.420-424, 2004. ,
DOI : 10.1136/gut.2002.009936
STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?, Gut, vol.55, issue.1, pp.123-130, 2006. ,
DOI : 10.1136/gut.2005.069757
Hepatitis C Virus-Induced Hepatocellular Steatosis, The American Journal of Gastroenterology, vol.116, issue.3, pp.711-715, 2005. ,
DOI : 10.1016/S0270-9139(03)80647-X
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity, Journal of Clinical Investigation, vol.115, issue.5, pp.1298-1305, 2005. ,
DOI : 10.1172/JCI200523057
Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats, Hepatology, vol.330, issue.1, pp.122-129, 2007. ,
DOI : 10.1002/hep.21641
CB2 receptor antagonism reduces diet-induced obesity, insulin resistance and hepatic steatosis, Hepatology, vol.46, p.308, 2007. ,
Daily Cannabis Use: A Novel Risk Factor of Steatosis Severity in Patients With Chronic Hepatitis C, Gastroenterology, vol.134, issue.2, 2008. ,
DOI : 10.1053/j.gastro.2007.11.039